Qnexa

Vivus Weight-Loss Pill Works - FDA
Vivus Weight-Loss Pill Works - FDA
TheStreet.com
FDA
diet drugs
obesity
Vivus
advisory panels
Qnexa
Arena Pharmaceuticals
Orexigen
Contrave
Flag link:
Why the FDA Will Likely Reject 3 New Weight Loss Drugs
Why the FDA Will Likely Reject 3 New Weight Loss Drugs
BNET Pharma
FDA
Vivus
obesity
Qnexa
Orexigen
Arena Pharmaceuticals
Contrave
Flag link:
Avandia, Qnexa Mean a Big Week for FDA Advisory Committee
Avandia, Qnexa Mean a Big Week for FDA Advisory Committee
WSJ Online
Qnexa
Avandia
FDA
GSK
diabetes
obesity
advisory panels
Vivus
Flag link:
Rodman & Renshaw lowers Vivus to 'Market Perform'
Rodman & Renshaw lowers Vivus to 'Market Perform'
Yahoo/AP
obesity
Qnexa
Vivus
Flag link:
How to Trade on an FDA Advisory Panel
How to Trade on an FDA Advisory Panel
Minyanville
FDA
advisory panels
Qnexa
Arena Pharmaceuticals
Vivus
Orexigen
Flag link:
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
Flag link:
Mark Your Calendars: Obesity Drugs Take Center Stage
Mark Your Calendars: Obesity Drugs Take Center Stage
Motley Fool
obesity
Orexigen
Qnexa
Vivus
Abbott Laboratories
GSK
Meridia
Alli
Flag link:
The Skinny on the Qnexa FDA Advisory Meeting
The Skinny on the Qnexa FDA Advisory Meeting
Minyanville
FDA
Qnexa
obesity
Vivus
advisory panels
Flag link:
New Obesity Pills: The Pipeline Getting Fat?
New Obesity Pills: The Pipeline Getting Fat?
CNBC
obesity
Vivus
Qnexa
Arena Pharmaceuticals
Orexigen
Contrave
Flag link:
Orexigen asks FDA for weight-loss drug approval
Orexigen asks FDA for weight-loss drug approval
Yahoo/AP
Orexigen
FDA
obesity
Contrave
Vivus
Arena Pharmaceuticals
Qnexa
Flag link:
FDA to Review VIVUS Drug
FDA to Review VIVUS Drug
Yahoo/Zacks.com
FDA
obesity
Vivus
Orexigen
Arena Pharmaceuticals
Qnexa
Amylin
Flag link:
Bulls Anticipating a Vivus Upside
Bulls Anticipating a Vivus Upside
Seeking Alpha
Vivus
obesity
Qnexa
Flag link:
FDA panel to review Vivus drug in July
FDA panel to review Vivus drug in July
Fierce Biotech
Vivus
FDA
obesity
Qnexa
Flag link:
3 Ways to Play the Obesity Drugs
3 Ways to Play the Obesity Drugs
TheStreet.com
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Contrave
Qnexa
lorcaserin
Flag link:
FDA accepts Vivus application for obesity drug
FDA accepts Vivus application for obesity drug
Marketwatch
FDA
Vivus
obesity
Qnexa
Flag link:
Five Drugs To Watch (Assuming FDA Approval)
Five Drugs To Watch (Assuming FDA Approval)
Pharmalot
FDA
Dendreon
Provenge
Victoza
Novo Nordisk
Qnexa
Vivus
Prolia
Amgen
Bayer
JNJ
Xarelto
Flag link:
Investors betting heavily on Vivus obesity drug
Investors betting heavily on Vivus obesity drug
Marketwatch
Vivus
obesity
Qnexa
Flag link:
Vivus says mid-stage study shows its obesity drug candidate Qnexa reduced sleep apnea symptoms
Vivus says mid-stage study shows its obesity drug candidate Qnexa reduced sleep apnea symptoms
Yahoo/AP
Vivus
Qnexa
sleep apnea
Flag link:
Vivus files application with FDA for obesity drug
Vivus files application with FDA for obesity drug
Marketwatch
FDA
Vivus
obesity
Qnexa
Flag link:
Obesity and ED: Two Big Markets, One Tiny Company
Obesity and ED: Two Big Markets, One Tiny Company
Minyanville
obesity
erectile dysfunction
Revive
Qnexa
Flag link:

Pages